Interventional technology developer AngioDynamics has enrolled the first patient in its Registry of AngioVac Procedures in Detail (RAPID) database at UCLA Health, the health system operated by the University of California, Los Angeles (UCLA).
The RAPID database is designed to evaluate AngioVac use patterns as well as the safety and effectiveness of the device in the en bloc removal of fresh, soft thrombi or emboli, according to the company. Dr. John Moriarty, director of cardiology-interventional radiology innovation at UCLA, said in a statement that centers in 31 states want to take part in the registry at this time.
